Clinical Trials in Salt Lake City

Showing 7501-7520 of 12,670 trials

Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal

NCT01573052

A randomized, double-blind controlled trial comparing treatment outcomes between chlordiazepoxide, or gabapentin to treat alcohol withdrawal syndrome in alcohol dependent veteran subjects. The objective of this trial is to compare the safety and effectiveness of these two medications. Intervention is a fixed dose taper of chlordiazepoxide, or gabapentin over 6 days. Subjects will be evaluated for 7-10 days to monitor alcohol abstinence, withdrawal severity scores, adverse events including ataxia, sedation, cognitive function and alcohol craving.

Alcohol Withdrawal

VA Salt Lake City Health Care System26 participantsStarted Mar 2004

Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

NCT00005970

This randomized phase III trial studies doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and trastuzumab to see how well they work compared to combination chemotherapy alone in treating women with breast cancer that is human epidermal growth factor receptor 2 (HER2)-positive and has spread to the lymph nodes or high-risk and has not spread to the lymph nodes. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether combination chemotherapy is more effective with or without trastuzumab in treating breast cancer.

Breast AdenocarcinomaHER2 Positive Breast CarcinomaStage IA Breast Cancer AJCC v7+4 more

National Cancer Institute (NCI)3,436 participantsStarted May 2000

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +154 more locations

Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Find Trials by Condition in Salt Lake City

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents

A Safety Study of NNZ-2566 in Pediatric Rett Syndrome

Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors

Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation

Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence

Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation

OIT and Xolair® (Omalizumab) in Cow's Milk Allergy

Clinical and Device Functional Assessment of Real World ICD Patients